Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Garin

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Antiviral Research|May 12, 2009
Inhibition of vaccinia virus replication by peptide aptamersLaurent Saccucci, Jean-Marc Crance, Pierre Colas, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2009
Inhibition of vaccinia virus replication by two small interfering RNAs targeting B1R and G7L genes and their synergistic combination with cidofovirSolenne Vigne, Sophie Duraffour, Graciela Andrei, et al.
Vaccine|December 9, 2008
Phenotypic and genetic diversity of the traditional Lister smallpox vaccineAude Garcel, Julien Perino, Jean-Marc Crance, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 2, 2004
Standardization of a neutralizing anti-vaccinia antibodies titration method: an essential step for titration of vaccinia immunoglobulins and smallpox vaccines evaluationIsabelle Leparc-Goffart, Bertrand Poirier, Daniel Garin, et al.
Bulletin De L'Academie Nationale De Medecine|January 2, 2007
[Evaluation of residual immune response against human pox virus before and after revaccination in healthy volunteers]François Bricaire, Behazine Combadière, Etienne Rouleau, et al.
Journal of Virology|April 26, 2012
Mutations conferring resistance to viral DNA polymerase inhibitors in camelpox virus give different drug-susceptibility profiles in vaccinia virusSophie Duraffour, Graciela Andrei, Dimitri Topalis, et al.
Biochemical and Biophysical Research Communications|June 11, 2002
NS3 protease of Langat tick-borne flavivirus cleaves serine protease substratesNatale Scaramozzino, Jean-Marc Crance, Christian Drouet, et al.
Nucleic Acids Research|August 9, 2003
Characterisation of the substrate specificity of homogeneous vaccinia virus uracil-DNA glycosylaseNatale Scaramozzino, Guenhael Sanz, Jean Marc Crance, et al.
Antiviral Therapy|June 25, 2008
Specific inhibition of orthopoxvirus replication by a small interfering RNA targeting the D5R geneSolenne Vigne, Raphaële Germi, Sophie Duraffour, et al.
Antiviral Research|November 25, 2010
Lung surfactant DPPG phospholipid inhibits vaccinia virus infectionJulien Perino, David Crouzier, Danièle Spehner, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Antiviral Research|May 12, 2009
Inhibition of vaccinia virus replication by peptide aptamersLaurent Saccucci, Jean-Marc Crance, Pierre Colas, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2009
Inhibition of vaccinia virus replication by two small interfering RNAs targeting B1R and G7L genes and their synergistic combination with cidofovirSolenne Vigne, Sophie Duraffour, Graciela Andrei, et al.
Vaccine|December 9, 2008
Phenotypic and genetic diversity of the traditional Lister smallpox vaccineAude Garcel, Julien Perino, Jean-Marc Crance, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 2, 2004
Standardization of a neutralizing anti-vaccinia antibodies titration method: an essential step for titration of vaccinia immunoglobulins and smallpox vaccines evaluationIsabelle Leparc-Goffart, Bertrand Poirier, Daniel Garin, et al.
Bulletin De L'Academie Nationale De Medecine|January 2, 2007
[Evaluation of residual immune response against human pox virus before and after revaccination in healthy volunteers]François Bricaire, Behazine Combadière, Etienne Rouleau, et al.
Journal of Virology|April 26, 2012
Mutations conferring resistance to viral DNA polymerase inhibitors in camelpox virus give different drug-susceptibility profiles in vaccinia virusSophie Duraffour, Graciela Andrei, Dimitri Topalis, et al.
Biochemical and Biophysical Research Communications|June 11, 2002
NS3 protease of Langat tick-borne flavivirus cleaves serine protease substratesNatale Scaramozzino, Jean-Marc Crance, Christian Drouet, et al.
Nucleic Acids Research|August 9, 2003
Characterisation of the substrate specificity of homogeneous vaccinia virus uracil-DNA glycosylaseNatale Scaramozzino, Guenhael Sanz, Jean Marc Crance, et al.
Antiviral Therapy|June 25, 2008
Specific inhibition of orthopoxvirus replication by a small interfering RNA targeting the D5R geneSolenne Vigne, Raphaële Germi, Sophie Duraffour, et al.
Antiviral Research|November 25, 2010
Lung surfactant DPPG phospholipid inhibits vaccinia virus infectionJulien Perino, David Crouzier, Danièle Spehner, et al.
Pageof 4